)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Atrys Health
Atrys Health (ATRY) investor relations material
Atrys Health Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary21 May, 2026
Executive summary
Revenue grew by 6.3% year-over-year in Q1 2026 to €37.5 million, driven by strong performances in Portugal, Latin America (notably Mexico), and Spain's radiology and radiotherapy segments.
EBITDA increased by 15.4% to €4.1 million, with notable growth in Oncology (+47.6%), Nuclear Medicine (+27.7%), and Diagnostic Imaging (+14.1%).
Net financial debt dropped by 81.1% after the Prevention/ASPY division sale, significantly improving financial efficiency and capital structure.
Operating cash flow surged 55.5% to €3.3 million, supported by EBITDA growth and a 44.7% reduction in CAPEX.
A new organisational model was implemented, focusing on geographical areas and management discipline to drive profitability and efficiency.
Financial highlights
Q1 2026 revenue: €37.5M (+6.3% YoY); EBITDA: €4.1M (+15.4% YoY); operating cash flow: €3.3M (+55.5% YoY).
Gross margin rose by 4.8% to €15.6M, with margin on revenue slightly normalising to 41.6%.
Capital expenditure reduced to €0.8M from €1.4M in Q1 2025, mainly due to lower R&D spend.
Net debt dropped by 81.1% versus December 2025, following the Prevention/ASPY division sale.
Financial expense savings of €2.4 million in Q1 2026.
Outlook and guidance
2026 guidance maintained: revenue +11%, reported EBITDA +40%, operating cash flow +125% (€13.5M).
Strategic plan for 2026–2028 to be presented in the coming months.
Strategy to recover Spanish Genetics margins
Sustainability of Mexico oncology revenue growth
Debt restructuring for 2026-2028 Strategic Plan
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Atrys Health
- Revenue up 8.5%, net debt slashed, Oncology drives growth, and strong 2026 outlook.ATRY
Q4 202531 Mar 2026 - Strong H1 growth in revenue and EBITDA, with 2024 guidance reaffirmed and profitability in sight.ATRYQ2 202427 Jan 2026
- 8.2% revenue growth driven by Oncology and Diagnostics; ASPY divestment to cut debt and refocus.ATRYQ3 20259 Dec 2025
- Revenue up 7.8% to €115.8M, net loss narrows, but margin and financial pressures persist.ATRYQ2 202513 Oct 2025
- Adjusted EBITDA up 31.7% and revenues up 7.2%, led by strong LATAM and Oncology growth.ATRYQ3 202413 Jun 2025
- Q1 2025 revenue up 11.2% and new CEO named to support continued growth and expansion.ATRYQ1 20259 Jun 2025
- Revenue and EBITDA grew, losses narrowed, but cash reserves declined sharply.ATRYQ4 20245 Jun 2025
Next Atrys Health earnings date
Q2 202631 Jul, 2026
Atrys Health
Next Atrys Health earnings date
Q2 202631 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage